bf/NASDAQ:LUCD_icon.jpeg

NASDAQ:LUCD

Lucid Diagnostics Inc.

  • Stock

USD

Last Close

1.07

06/11 21:56

Market Cap

44.21M

Beta: -

Volume Today

768.66K

Avg: 95.62K

PE Ratio

−0.03

PFCF: −2.29

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
416.88K
-
663.38K
59.13%
302K
54.48%
139.06M
45,944.87%
average payables
1.43M
-
1.77M
24.19%
1.27M
28.23%
1.10M
13.51%
average receivables
100K
-
108.50K
8.50%
31K
71.43%
book value per share
-0.14
-
-0.37
154.62%
2.94
905.16%
0.64
78.35%
-0.06
108.69%
capex per share
-0.05
-
-0.03
45.83%
-0.01
78.92%
capex to depreciation
-215.50
-
-0.47
99.78%
-0.09
81.14%
capex to operating cash flow
0.05
-
0.03
37.31%
0.01
77.98%
capex to revenue
-1.72
-
-2.41
39.70%
-0.09
96.22%
cash per share
0.00
-
0.00
28.87%
2.88
95,798.11%
0.62
78.46%
0.45
27.16%
days of inventory on hand
307.60
-
11.21
96.36%
11.97K
106,661.96%
days payables outstanding
929.66
-
106.65
88.53%
49.34
53.74%
days sales outstanding
146
-
16.46
88.73%
6.76
58.90%
debt to assets
0.06
-
7.85
12,665.36%
debt to equity
0.09
-
-92.62
106,889.63%
dividend yield
earnings yield
-0.01
-
-0.02
87.30%
-0.29
1,411.40%
-1.14
296.94%
-0.89
21.66%
enterprise value
434.87M
-
434.92M
0.01%
46.25M
89.37%
28.72M
37.90%
55.24M
92.33%
enterprise value over ebitda
-98.37
-
-52.53
46.60%
-1.69
96.79%
-0.53
68.61%
-1.20
126.84%
ev to operating cash flow
-184.16
-
-77.27
58.04%
-2.62
96.61%
-0.97
63.04%
-1.68
73.97%
ev to sales
92.49
-
76.18
17.64%
22.75
70.14%
free cash flow per share
-0.06
-
-0.15
138.36%
-1.00
554.61%
-0.85
15.09%
-0.79
6.45%
free cash flow yield
-0.01
-
-0.01
138.36%
-0.19
1,333.56%
-0.62
235.28%
-0.56
9.77%
graham net net
-0.17
-
-0.41
145.44%
2.68
752.02%
0.36
86.49%
3.07
750.03%
graham number
0.62
-
1.36
118.38%
10.11
645.45%
4.72
53.34%
1.25
73.44%
income quality
0.53
-
0.68
27.26%
0.63
7.44%
0.53
16.01%
0.62
17.91%
intangibles to total assets
0
-
0
0
0.11
Infinity%
52.22
49,176.43%
interest coverage
-41.61
-
0.12
-
interest debt per share
0.04
-
0.06
56.01%
-4.84
8,851.36%
inventory turnover
1.19
-
32.56
2,643.82%
0.03
99.91%
invested capital
0.09
-
-92.62
106,889.63%
market cap
435.03M
-
435.03M
0%
99.90M
77.04%
49.19M
50.76%
58.88M
19.68%
net current asset value
-5.95M
-
-14.27M
139.80%
53.04M
471.62%
14.89M
71.92%
-7.51M
150.41%
net debt to ebitda
0.04
-
0.01
62.02%
1.96
14,465.17%
0.38
80.71%
0.08
79.03%
net income per share
-0.12
-
-0.22
87.30%
-1.54
590.16%
-1.55
0.53%
-1.26
18.78%
operating cash flow per share
-0.06
-
-0.15
138.36%
-0.95
524.16%
-0.82
13.59%
-0.79
4.23%
payables turnover
0.39
-
3.42
771.68%
7.40
116.16%
receivables turnover
2.50
-
22.18
787.06%
53.96
143.30%
research and ddevelopement to revenue
18.59
-
30.41
63.59%
2.99
90.18%
return on tangible assets
-4.28
-
-3.77
11.77%
-0.49
87.09%
-1.93
296.79%
0.04
101.95%
revenue per share
0.03
-
0.01
61.22%
0.06
457.91%
roe
0.83
-
0.61
26.44%
-0.52
185.72%
-2.44
364.25%
22.79
1,035.05%
roic
0.83
-
0.61
26.44%
-0.51
183.70%
-2.08
305.13%
-0.23
88.99%
sales general and administrative to revenue
25.56
-
62.82
145.83%
7.93K
12,522.35%
shareholders equity per share
-0.14
-
-0.37
154.62%
2.94
905.16%
0.64
78.35%
-0.06
108.69%
stock based compensation to revenue
19.20
-
39.76
107.13%
2.37K
5,868.09%
tangible asset value
-5.31M
-
-13.52M
154.62%
54.74M
504.92%
19.60M
64.19%
-1.43B
7,376.35%
tangible book value per share
-0.14
-
-0.37
154.62%
2.94
905.16%
0.54
81.58%
-34.16
6,403.35%
working capital
-5.95M
-
-14.27M
139.80%
53.04M
471.62%
15.93M
69.97%
-7.31M
145.88%

All numbers in USD (except ratios and percentages)